These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32162806)

  • 1. An Analysis of Recent FDA Oncology Scientific Publications.
    Schneider JA; Miklos AC; Onken J; Gong Y; Calcagno AM; Blumenthal GM; Aragon R; Pazdur R
    Oncologist; 2020 Mar; 25(3):266-270. PubMed ID: 32162806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of National Institutes of Health and Food and Drug Administration Tobacco Research Funding: A Bibliometrics Analyses.
    Sharma K; Moyer J; Liggins C; Garcia-Cazarin M; Mandal RJ; Wanke KL; Meissner HI
    Nicotine Tob Res; 2023 May; 25(6):1082-1089. PubMed ID: 36789895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Reported Outcomes Labeling for Products Approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010-2014).
    Gnanasakthy A; DeMuro C; Clark M; Haydysch E; Ma E; Bonthapally V
    J Clin Oncol; 2016 Jun; 34(16):1928-34. PubMed ID: 27069082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA Oncology Center of Excellence Scientific Collaborative: Charting a Course for Applied Regulatory Science Research in Oncology.
    Schneider JA; Gong Y; Goldberg KB; Kluetz PG; Theoret MR; Amiri-Kordestani L; Beaver JA; Fashoyin-Aje L; Gormley NJ; Jaigirdar AA; Lemery SJ; Mishra-Kalyani PS; Reaman GH; Rivera DR; Rubinstein WS; Singh H; Sridhara R; Pazdur R
    Clin Cancer Res; 2021 Oct; 27(19):5161-5167. PubMed ID: 33910935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pagerank-Index: Going beyond Citation Counts in Quantifying Scientific Impact of Researchers.
    Senanayake U; Piraveenan M; Zomaya A
    PLoS One; 2015; 10(8):e0134794. PubMed ID: 26288312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citations in Life Science Patents to Publicly Funded Research at Academic Medical Centers.
    Sampat BN; Pincus HA
    Clin Transl Sci; 2015 Dec; 8(6):759-63. PubMed ID: 26728947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Authors in Dermatologic Surgery.
    Nguyen NQ; Moy RL
    Dermatol Surg; 2000 Dec; 26(12):1092-5. PubMed ID: 11134983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Oncology and Hematology Drug Approvals at US Food and Drug Administration Between 2008 and 2016.
    Zhou J; Vallejo J; Kluetz P; Pazdur R; Kim T; Keegan P; Farrell A; Beaver JA; Sridhara R
    J Natl Cancer Inst; 2019 May; 111(5):449-458. PubMed ID: 30085269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misrepresentation of publications among radiation oncology residency applicants.
    Yang GY; Schoenwetter MF; Wagner TD; Donohue KA; Kuettel MR
    J Am Coll Radiol; 2006 Apr; 3(4):259-64. PubMed ID: 17412057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FDA Oncology Center of Excellence and precision medicine.
    Goldberg KB; Blumenthal GM; McKee AE; Pazdur R
    Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Published Clinical Study Reports to Support U.S. Food and Drug Administration Approval of Imaging Agents.
    Rieves D; Jacobs P
    J Nucl Med; 2016 Dec; 57(12):2022-2026. PubMed ID: 27445294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in complementary and alternative medicine: contribution of the National Institutes of Health and the Food and Drug Administration.
    Eskinazi D; Hoffman FA
    J Altern Complement Med; 1998; 4(4):459-67. PubMed ID: 9884181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coauthor Country Affiliations in International Collaborative Research Funded by the US National Institutes of Health, 2009 to 2017.
    Grubbs JC; Glass RI; Kilmarx PH
    JAMA Netw Open; 2019 Nov; 2(11):e1915989. PubMed ID: 31755947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine.
    Witten CM; McFarland RD; Simek SL
    Stem Cells Transl Med; 2015 Dec; 4(12):1495-9. PubMed ID: 26494784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges with sex-specific subgroup analyses in oncology clinical trials for drug approvals between 2015-2020.
    Jenei K; Raymakers A; Meyers DE; Prasad V
    J Cancer Policy; 2021 Dec; 30():100311. PubMed ID: 35559802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.
    Chang L; Dhruva SS; Chu J; Bero LA; Redberg RF
    BMJ; 2015 Jun; 350():h2613. PubMed ID: 26063311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conflict of interest in oncology publications: a survey of disclosure policies and statements.
    Kesselheim AS; Lee JL; Avorn J; Servi A; Shrank WH; Choudhry NK
    Cancer; 2012 Jan; 118(1):188-95. PubMed ID: 21717432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
    Høilund-Carlsen PF
    Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship Between Preresidency Peer-Reviewed Publications and Subsequent Citation-Based Scholarly Activity of United States Radiation Oncology Residents.
    McClelland S; Jaboin JJ
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):666-668. PubMed ID: 29960058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Real-World Evidence to Support FDA Approval of Oncology Drugs.
    Feinberg BA; Gajra A; Zettler ME; Phillips TD; Phillips EG; Kish JK
    Value Health; 2020 Oct; 23(10):1358-1365. PubMed ID: 33032780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.